Seeing Cancer with New Precision
Current diagnostic tools either lack molecular clarity or rely on harmful radiation.
MRI/CT: Excellent structure, poor molecular detail, often toxic or radioactive.
PET/SPECT: Molecular data, but limited resolution, expensive, and radiation-based.
The Problem
The ACE Solution
ACE’s proprietary technology provides:
Dual Imaging in a Single Agent: Photoacoustic + fluorescence imaging for full diagnostic insight.
Zero Radiation: Uses harmless near-infrared light (NIR-I and NIR-II/SWIR).
Superior Depth: 3–5 cm imaging range with exceptional clarity.
Targeted Accuracy: Antibody-conjugated nanoparticles seek cancer-specific markers.
Real-Time Surgical Visualization: Enables oncologists to remove tumors precisely while preserving healthy tissue.